Cargando…

Abnormal expression of SIRTs in psoriasis: Decreased expression of SIRT 1-5 and increased expression of SIRT 6 and 7

The prevalence of psoriasis is increasing, and poses a serious risk to human health and quality of life. Psoriasis, a chronic immune-mediated skin disease with epidermal hyperkeratosis and parakeratosis, is associated with numerous complications, including metabolic syndromes that are regulated by s...

Descripción completa

Detalles Bibliográficos
Autores principales: Fan, Xiaojing, Yan, Kexiang, Meng, Qinqin, Sun, Rui, Yang, Xinrong, Yuan, Dingfen, Li, Fulun, Deng, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6559298/
https://www.ncbi.nlm.nih.gov/pubmed/31017270
http://dx.doi.org/10.3892/ijmm.2019.4173
_version_ 1783425807181414400
author Fan, Xiaojing
Yan, Kexiang
Meng, Qinqin
Sun, Rui
Yang, Xinrong
Yuan, Dingfen
Li, Fulun
Deng, Hui
author_facet Fan, Xiaojing
Yan, Kexiang
Meng, Qinqin
Sun, Rui
Yang, Xinrong
Yuan, Dingfen
Li, Fulun
Deng, Hui
author_sort Fan, Xiaojing
collection PubMed
description The prevalence of psoriasis is increasing, and poses a serious risk to human health and quality of life. Psoriasis, a chronic immune-mediated skin disease with epidermal hyperkeratosis and parakeratosis, is associated with numerous complications, including metabolic syndromes that are regulated by sirtuins (SIRTs) via deacetylation. As they serve a necessary function in inflammation and metabolism, SIRTs are considered to link inflammation and metabolic syndrome. Previous studies have indicated that SIRTs serve a function in the pathophysiology of psoriasis, but to date no detailed research has been conducted investigating the expression levels and patterns of SIRTs in psoriasis. The present study investigated the abnormal expression of SIRTs in psoriasis and provided a theoretical foundation for the treatment and prognosis of psoriasis. Tumor necrosis factor (TNF)-α-stimulated HaCaT cells and an imiquimod-induced psoriasis mouse model were used to produce in vitro and in vivo models, respectively. Psoriasis clinical specimens (psoriasis area and severity index >10; n=22) and normal group specimens (n=22) were obtained from human subjects. The mRNA and protein expression levels in human and mouse skin lesions and TNF-α-stimulated HaCaT cells were detected using reverse transcription-quantitative polymerase chain reaction (RT-qPCR) and western blotting, and compared with the control groups. The expression patterns of SIRT proteins were investigated using immunofluorescence (IF) staining. The expression levels of SIRT1, SIRT2, SIRT3, SIRT4 and SIRT5 were downregulated while those of SIRT6 and SIRT7 were upregulated in skin lesions and TNF-α-stimulated HaCaT cells compared with the control group as determined by RT-qPCR, western blotting and IF. Statistically significant differences were observed in vivo and in vitro. P-values of SIRT1-7 mRNA are less than 0.05 in RT-qPCR, and the P-values of SIRT1-7 proteins are less than 0.05 except for SIRT4 in the western blot analysis. SIRTs serve notable functions in severe psoriasis dermatitis, with the overexpression of SIRT6 and SIRT7 potentially induced by the adaptive immune response, and the downregulation of SIRT1, SIRT2, SIRT3, SIRT4 and SIRT5 may be a result of an internal environment imbalance in vivo. Psoriasis is an inflammation and metabolism-associated disease mediated by the SIRT family. The present results provide a novel potential mechanism and strategy for the treatment of psoriasis by modulating the function and expression of SIRTs.
format Online
Article
Text
id pubmed-6559298
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-65592982019-06-12 Abnormal expression of SIRTs in psoriasis: Decreased expression of SIRT 1-5 and increased expression of SIRT 6 and 7 Fan, Xiaojing Yan, Kexiang Meng, Qinqin Sun, Rui Yang, Xinrong Yuan, Dingfen Li, Fulun Deng, Hui Int J Mol Med Articles The prevalence of psoriasis is increasing, and poses a serious risk to human health and quality of life. Psoriasis, a chronic immune-mediated skin disease with epidermal hyperkeratosis and parakeratosis, is associated with numerous complications, including metabolic syndromes that are regulated by sirtuins (SIRTs) via deacetylation. As they serve a necessary function in inflammation and metabolism, SIRTs are considered to link inflammation and metabolic syndrome. Previous studies have indicated that SIRTs serve a function in the pathophysiology of psoriasis, but to date no detailed research has been conducted investigating the expression levels and patterns of SIRTs in psoriasis. The present study investigated the abnormal expression of SIRTs in psoriasis and provided a theoretical foundation for the treatment and prognosis of psoriasis. Tumor necrosis factor (TNF)-α-stimulated HaCaT cells and an imiquimod-induced psoriasis mouse model were used to produce in vitro and in vivo models, respectively. Psoriasis clinical specimens (psoriasis area and severity index >10; n=22) and normal group specimens (n=22) were obtained from human subjects. The mRNA and protein expression levels in human and mouse skin lesions and TNF-α-stimulated HaCaT cells were detected using reverse transcription-quantitative polymerase chain reaction (RT-qPCR) and western blotting, and compared with the control groups. The expression patterns of SIRT proteins were investigated using immunofluorescence (IF) staining. The expression levels of SIRT1, SIRT2, SIRT3, SIRT4 and SIRT5 were downregulated while those of SIRT6 and SIRT7 were upregulated in skin lesions and TNF-α-stimulated HaCaT cells compared with the control group as determined by RT-qPCR, western blotting and IF. Statistically significant differences were observed in vivo and in vitro. P-values of SIRT1-7 mRNA are less than 0.05 in RT-qPCR, and the P-values of SIRT1-7 proteins are less than 0.05 except for SIRT4 in the western blot analysis. SIRTs serve notable functions in severe psoriasis dermatitis, with the overexpression of SIRT6 and SIRT7 potentially induced by the adaptive immune response, and the downregulation of SIRT1, SIRT2, SIRT3, SIRT4 and SIRT5 may be a result of an internal environment imbalance in vivo. Psoriasis is an inflammation and metabolism-associated disease mediated by the SIRT family. The present results provide a novel potential mechanism and strategy for the treatment of psoriasis by modulating the function and expression of SIRTs. D.A. Spandidos 2019-07 2019-04-24 /pmc/articles/PMC6559298/ /pubmed/31017270 http://dx.doi.org/10.3892/ijmm.2019.4173 Text en Copyright: © Fan et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Articles
Fan, Xiaojing
Yan, Kexiang
Meng, Qinqin
Sun, Rui
Yang, Xinrong
Yuan, Dingfen
Li, Fulun
Deng, Hui
Abnormal expression of SIRTs in psoriasis: Decreased expression of SIRT 1-5 and increased expression of SIRT 6 and 7
title Abnormal expression of SIRTs in psoriasis: Decreased expression of SIRT 1-5 and increased expression of SIRT 6 and 7
title_full Abnormal expression of SIRTs in psoriasis: Decreased expression of SIRT 1-5 and increased expression of SIRT 6 and 7
title_fullStr Abnormal expression of SIRTs in psoriasis: Decreased expression of SIRT 1-5 and increased expression of SIRT 6 and 7
title_full_unstemmed Abnormal expression of SIRTs in psoriasis: Decreased expression of SIRT 1-5 and increased expression of SIRT 6 and 7
title_short Abnormal expression of SIRTs in psoriasis: Decreased expression of SIRT 1-5 and increased expression of SIRT 6 and 7
title_sort abnormal expression of sirts in psoriasis: decreased expression of sirt 1-5 and increased expression of sirt 6 and 7
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6559298/
https://www.ncbi.nlm.nih.gov/pubmed/31017270
http://dx.doi.org/10.3892/ijmm.2019.4173
work_keys_str_mv AT fanxiaojing abnormalexpressionofsirtsinpsoriasisdecreasedexpressionofsirt15andincreasedexpressionofsirt6and7
AT yankexiang abnormalexpressionofsirtsinpsoriasisdecreasedexpressionofsirt15andincreasedexpressionofsirt6and7
AT mengqinqin abnormalexpressionofsirtsinpsoriasisdecreasedexpressionofsirt15andincreasedexpressionofsirt6and7
AT sunrui abnormalexpressionofsirtsinpsoriasisdecreasedexpressionofsirt15andincreasedexpressionofsirt6and7
AT yangxinrong abnormalexpressionofsirtsinpsoriasisdecreasedexpressionofsirt15andincreasedexpressionofsirt6and7
AT yuandingfen abnormalexpressionofsirtsinpsoriasisdecreasedexpressionofsirt15andincreasedexpressionofsirt6and7
AT lifulun abnormalexpressionofsirtsinpsoriasisdecreasedexpressionofsirt15andincreasedexpressionofsirt6and7
AT denghui abnormalexpressionofsirtsinpsoriasisdecreasedexpressionofsirt15andincreasedexpressionofsirt6and7